+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Regeneron Pharmaceuticals Inc - logo

Regeneron is a biotechnology company with its headquarters in New York City. Their product portfolio includes Praluent, Eylea and Arcalyst. Regeneron is a key player in research and development including drug discovery, human antibody technologies and genomics. Regeneron scientists focus on discovering new drug targets and developing effective product candidates through the proprietary VelociSuite platform of genetic technologies. In 2015 Regeneron announced a new collaboration with Sanofi to develop immuno-oncology treatments with a plan to begin clinical trials in 2016.

From
Atopic Keratoconjunctivitis - Pipeline Insight, 2021 - Product Thumbnail Image

Atopic Keratoconjunctivitis - Pipeline Insight, 2021

  • Clinical Trials
  • September 2021
  • 60 Pages
  • Global
From
Transforming Growth Factor (TGF) Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

Transforming Growth Factor (TGF) Inhibitor - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
From
From
Retinopathy Of Prematurity - Pipeline Review, H2 2020 - Product Thumbnail Image

Retinopathy Of Prematurity - Pipeline Review, H2 2020

  • Drug Pipelines
  • September 2020
  • 68 Pages
  • Global
From
Fianlimab (REGN3767) Emerging Drug Insight and Market Forecast - 2035 - Product Thumbnail Image

Fianlimab (REGN3767) Emerging Drug Insight and Market Forecast - 2035

  • Drug Pipelines
  • December 2022
  • 30 Pages
  • Global
From
Loading Indicator